Related Experiment Video

Updated: Jan 5, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.4K

PGC-1α inhibits polyamine metabolism in Cyclin E1-driven ovarian cancer

Ting Guo1, Bin Li1, Chao Gu1

  • 1Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, PR China.

Cancer Medicine
|October 29, 2019
PubMed
Abstract

Insights

Cyclin E1-driven ovarian cancer exhibits altered polyamine metabolism, linked to reduced immunity. Targeting polyamine synthesis and CDK2 may enhance responses to immune checkpoint blockade therapy.

Area of Science:

  • Oncology
  • Metabolic pathways
  • Cancer immunology

Background:

  • Cyclin E1-driven ovarian cancer (OvCa) displays significant metabolic alterations.
  • Understanding these metabolic shifts is crucial for identifying novel therapeutic targets.

Purpose of the Study:

  • To identify the specific metabolic pathway dysregulated in Cyclin E1-driven OvCa.
  • To evaluate the therapeutic potential of targeting this pathway.

Main Methods:

  • In silico analysis of TCGA ovarian cancer dataset using Gene Set Enrichment Analysis (GSEA).
  • In vitro and in vivo validation of candidate metabolic pathways.
  • Assessment of cell invasion, migration, and immune marker expression.

Main Results:

  • Polyamine metabolism was significantly enriched in Cyclin E1-driven OvCa.
  • Expressions of SMS, SRM, and ODC1 correlated with CCNE1 and decreased immune infiltrates.
  • Targeting polyamine synthesis (SRM) and CDK2 (Dinaciclib) reduced invasion/migration and modulated immune markers (PD-L1/PD-L2).

Conclusions:

  • Activated polyamine synthesis in Cyclin E1-driven OvCa is associated with diminished cancer immunity.
  • Targeting polyamine metabolism and CDK2 may sensitize this ovarian cancer subtype to immune checkpoint blockade.
Keywords:
CCNE1High-grade serous ovarian cancerpolyamine metabolism

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.7K
Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time14:25

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

17.7K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.4K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
133.5K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K